Ibogaine Research Database

692 research records indexed from PubMed. Plain-language summaries where available.

Of these, 52 are human clinical studies (trials, observational studies, or case reports), 398 are preclinical (animal or lab) studies, and 112 are reviews or meta-analyses summarizing other researchers’ data. A record appearing here does not by itself mean ibogaine is proven effective for a given condition — see each condition page’s evidence breakdown for what’s actually established.

Compare evidence by condition →

All Studies (692)Depression (56)PTSD (24)Alcohol Addiction (20)Heroin Addiction (16)Opioid Addiction (15)Cocaine Addiction (15)Anxiety (13)Methamphetamine Addiction (12)Traumatic Brain Injury (2)

All Studies(692 of 692)

The anti-addiction drug ibogaine and the heart: a delicate relation.

Koenig, Hilber· Molecules· 2015· PMID: 25642835
Review

The plant indole alkaloid ibogaine has shown promising anti-addictive properties in animal studies. Ibogaine is also anti-addictive in humans as the drug alleviates drug craving and impedes relapse of drug use. Although not licensed as therapeutic drug and despite safety concerns...

Soma, food of the immortals according to the Bower Manuscript (Kashmir, 6th century A.D.).

Leonti, Casu· J Ethnopharmacol· 2014· PMID: 24907429
Unclassified

Food is medicine and vice versa. In Hindu and Ayurvedic medicine, and among human cultures of the Indian subcontinent in general, the perception of the food-medicine continuum is especially well established. The preparation of the exhilarating, gold-coloured Soma, Amrita or Ambro...

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Emerson, Ponté, Jerome et al.· J Psychoactive Drugs· 2014· PMID: 24830183
Unclassified

This article describes the teenage vision of the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) that humanity's future would be aided by the therapeutic and spiritual potential of psychedelic substances. The article traces the trajectory of MAPS from ...

A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.

El-Kasaby, Koban, Sitte et al.· J Biol Chem· 2014· PMID: 25202009
Unclassified

Mutations in the C terminus of the serotonin transporter (SERT) disrupt folding and export from the endoplasmic reticulum. Here we examined the hypothesis that a cytosolic heat shock protein relay was recruited to the C terminus to assist folding of SERT. This conjecture was veri...

Synthesis of (-)-pseudotabersonine, (-)-pseudovincadifformine, and (+)-coronaridine enabled by photoredox catalysis in flow.

Beatty, Stephenson· J Am Chem Soc· 2014· PMID: 25003992
Preclinical (Lab)

Natural product modification with photoredox catalysis allows for mild, chemoselective access to a wide array of related structures in complex areas of chemical space, providing the possibility for novel structural motifs as well as useful quantities of less abundant congeners. W...

Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.

Condello, Cosentino, Corinti et al.· J Nat Prod· 2014· PMID: 24720452
Unclassified

In previous studies it has been demonstrated that the plant alkaloid voacamine (1), used at noncytotoxic concentrations, enhanced the cytotoxicity of doxorubicin and exerted a chemosensitizing effect on cultured multidrug-resistant (MDR) U-2 OS-DX osteosarcoma cells. The in vitro...

Screening and identification of neuroprotective compounds relevant to Alzheimer׳s disease from medicinal plants of S. Tomé e Príncipe.

Currais, Chiruta, Goujon-Svrzic et al.· J Ethnopharmacol· 2014· PMID: 24971794
Preclinical (Animal)

Alzheimer׳s disease (AD) neuropathology is strongly associated with the activation of inflammatory pathways, and long-term use of anti-inflammatory drugs reduces the risk of developing the disease. In S. Tomé e Príncipe (STP), several medicinal plants are used both for their posi...

Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.

Terada, Horie, Takayama et al.· J Nat Prod· 2014· PMID: 24484240
Unclassified

Voacangine (1) is an alkaloid found in the root bark of Voacanga africana. Our previous work has suggested that 1 is a novel transient receptor potential vanilloid type 1 (TRPV1) antagonist. In this study, the agonist and antagonist activities of 1 were examined against thermosen...

Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.

Terada, Kitajima, Taguchi et al.· J Nat Prod· 2014· PMID: 25052206
Preclinical (Lab)

The iboga alkaloid voacangine (1) has been reported previously to be the first stimulus-selective TRPM8 antagonist. In the present report, a structure-activity relationship (SAR) study is described on the effects of some naturally occurring indole alkaloid analogues on TRPM8 inhi...

A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine sc

Meyer, Caspar, Brandt et al.· Anal Bioanal Chem· 2014· PMID: 24173660
Unclassified

The first synthetic tryptamines have entered the designer drug market in the late 1990s and were distributed as psychedelic recreational drugs. In the meantime, several analogs have been brought onto the market indicating a growing interest in this drug class. So far, only scarce...

Cardiac arrest after ibogaine ingestion.

Vlaanderen, Martial, Franssen et al.· Clin Toxicol (Phila)· 2014· PMID: 24940646
Case Report

Iboga-Type Alkaloids from Ervatamia officinalis.

Tang, Wang, Huang et al.· J Nat Prod· 2014· PMID: 25093992
Preclinical (Lab)

Seven new iboga-type alkaloids, ervaoffines A-D (1-4), (7S)-3-oxoibogaine hydroxyindolenine (5), ibogaine-5,6-dione (6), and 19-epi-5-oxovoacristine (7), and 10 known alkaloids were isolated from Ervatamia officinalis. The absolute configurations of 1-7 were determined through X-...

Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.

Thurner, Stary-Weinzinger, Gafar et al.· J Pharmacol Exp Ther· 2014· PMID: 24307198
Unclassified

Ibogaine is a psychoactive indole alkaloid. Its use as an antiaddictive agent has been accompanied by QT prolongation and cardiac arrhythmias, which are most likely caused by human ether a go-go-related gene (hERG) potassium channel inhibition. Therefore, we studied in detail the...

Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.

Koenig, Kovar, Boehm et al.· Addict Biol· 2014· PMID: 22458604
Preclinical (Animal)

Ibogaine, an alkaloid derived from the African shrub Tabernanthe iboga, has shown promising anti-addictive properties in animals. Anecdotal evidence suggests that ibogaine is also anti-addictive in humans. Thus, it alleviates drug craving and impedes relapse of drug use. Although...

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.

Winkelman· Curr Drug Abuse Rev· 2014· PMID: 25563446
Review

Substances known as psychedelics, hallucinogens and entheogens have been employed in ethnomedical traditions for thousands of years, but after promising uses in the 1950's and 1960's they were largely prohibited in medical treatment and human research starting in the 1970's as pa...

Treating drug dependence with the aid of ibogaine: a retrospective study.

Schenberg, de Castro Comis, Chaves· Journal of psychopharmacology (Oxford, England)· 2014· PMID: 25271214
Observational Study

Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Bra...

Thermostabilisation of the serotonin transporter in a cocaine-bound conformation.

Abdul-Hussein, Andréll, Tate· J Mol Biol· 2013· PMID: 23706649
Preclinical (Animal)

Structure determination of mammalian integral membrane proteins is challenging due to their instability upon detergent solubilisation and purification. Recent successes in the structure determination of G-protein-coupled receptors (GPCRs) resulted from the development of GPCR-spe...

Determination of antiplasmodial activity and binding affinity of selected natural products towards PfTrxR and PfGR.

Munigunti, Becker, Brun et al.· Nat Prod Commun· 2013· PMID: 24079187
Preclinical (Animal)

In our study, the binding affinities of selected natural products towards PfTrxR, PfGR, human TrxR and human GR were determined using a mass spectrometry based ligand binding assay. The in vitro antimalarial activity and cytotoxicity of these ligands were also determined. Cathara...

3'-R/S-hydroxyvoacamine, a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata.

Chaiyana, Schripsema, Ingkaninan et al.· Phytomedicine· 2013· PMID: 23375813
Unclassified

Guided by the acetylcholinesterase inhibiting activity, the bisindole alkaloid 3'-R/S-hydroxyvoacamine was isolated from a stem extract of Tabernaemontana divaricata, a plant used in Thailand in traditional rejuvenation remedies for improving the memory. The structure of the alka...

Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations.

Koldsø, Autzen, Grouleff et al.· PLoS One· 2013· PMID: 23776432
Unclassified

The competitive inhibitor cocaine and the non-competitive inhibitor ibogaine induce different conformational states of the human serotonin transporter. It has been shown from accessibility experiments that cocaine mainly induces an outward-facing conformation, while the non-compe...

Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.

Antonio, Childers, Rothman et al.· PLoS One· 2013· PMID: 24204784
Preclinical (Animal)

The iboga alkaloids are a class of small molecules defined structurally on the basis of a common ibogamine skeleton, some of which modify opioid withdrawal and drug self-administration in humans and preclinical models. These compounds may represent an innovative approach to neuro...

Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material.

Mazoyer, Carlier, Boucher et al.· J Forensic Sci· 2013· PMID: 23919354
Case Report

We report the case of a man who died twelve hours after ingesting powdered iboga root, commonly taken for its stimulant and hallucinogenic properties. Ibogaine and ibogamine were quantified in the powder ingested and the victim's body fluids by GC-MS/MS after liquid-liquid extrac...

Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research.

Cachat, Kyzar, Collins et al.· Behav Brain Res· 2013· PMID: 22974549
Preclinical (Animal)

An indole alkaloid, ibogaine is the principal psychoactive component of the iboga plant, used by indigenous peoples in West Africa for centuries. Modulating multiple neurotransmitter systems, the drug is a potent hallucinogen in humans, although its psychotropic effects remain po...

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Koenig, Kovar, Rubi et al.· Toxicol Appl Pharmacol· 2013· PMID: 23707769
Preclinical (Animal)

The plant alkaloid ibogaine has promising anti-addictive properties. Albeit not licensed as a therapeutic drug, and despite hints that ibogaine may perturb the heart rhythm, this alkaloid is used to treat drug addicts. We have recently reported that ibogaine inhibits human ERG (h...

Ibogaine related sudden death: a case report.

Papadodima, Dona, Evaggelakos et al.· J Forensic Leg Med· 2013· PMID: 24112325
Case Report

Ibogaine is a naturally occurring alkaloid derived from the roots of the rain forest shrub Tabernanthe iboga. Deaths have occurred temporarily related to the use of ibogaine. However, although not licensed as therapeutic drug, and despite evidence that ibogaine may disturb the rh...

Growing menace of ibogaine toxicity.

Asua· Br J Anaesth· 2013· PMID: 24233315
Case Report

Ibogaine in the treatment of substance dependence.

Brown· Curr Drug Abuse Rev· 2013· PMID: 23627782
Review

Ibogaine is a psychoactive alkaloid derived from Tabernanthe iboga, a plant used in initiatory rituals in West Central Africa. Largely because of ibogaine's status as a Schedule I substance in the U.S., the development of ibogaine's use in the treatment of drug addiction took pla...

A case of death due to ibogaine use for heroin addiction: case report.

Jalal, Daher, Hilu· The American journal on addictions· 2013· PMID: 23617876
Case Report

Phytotherapy of alcoholism.

Tomczyk, Zovko-Koncić, Chrostek· Natural product communications· 2012· PMID: 22474979
Review

Alcoholism is a medical, social, and economic problem where treatment methods mostly include difficult and long-lasting psychotherapy and, in some cases, quite controversial pharmacological approaches. A number of medicinal plants and pure natural compounds are reported to have p...

Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.

Ross· Psychiatr Clin North Am· 2012· PMID: 22640760
Preclinical (Animal)

Only time will tell if serotonergic hallucinogen-assisted psychotherapy treatment paradigms for SUDs will prove to be safe and effective in double-blind, placebo-controlled clinical trials. If they are, they would truly constitute a novel psychopharmacologic-psychosocial treatmen...

A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo.

Kim, Jung, Kwon· Biochem Biophys Res Commun· 2012· PMID: 22155252
Preclinical (Animal)

Angiogenesis, the formation of new blood vessels from pre-existing ones, plays a critical role in normal and pathological phenotypes, including solid tumor growth and metastasis. Accordingly, the development of new anti-angiogenic agents is considered an efficient strategy for th...

[Study on the alkaloids constituents from Voacanga africana].

Mei, Deng, Li et al.· Zhong Yao Cai· 2012· PMID: 22822667
Preclinical (Lab)

To study the alkaloids of Voacanga africana. The alkaloids were isolated by normal phase silica gel and Sephadex LH-20 column chromatography. Their structures were elucidated by analysis of spectroscopic data. Eight alkaloids were isolated and their structures were elucidated as ...

Effect of an alkaloidal fraction of Tabernaemontana elegans (Stapf.) on selected micro-organisms.

Pallant, Cromarty, Steenkamp· J Ethnopharmacol· 2012· PMID: 22313627
Unclassified

Bacterial infections remain a significant threat to human health. Due to the emergence of widespread antibiotic resistance, development of novel antibiotics is required in order to ensure that effective treatment remains available. There are several reports on the ethnomedical us...

α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.

McCallum, Cowe, Lewis et al.· Neuropharmacology· 2012· PMID: 22561751
Preclinical (Animal)

Habenulo-interpeduncular nicotinic receptors, particularly those containing α3, β4 and α5 subunits, have recently been implicated in the reinforcing effects of nicotine. Our laboratory has shown that injection of α3β4 nicotinic receptor antagonists into the medial habenula (MHb) ...

18-Methoxycoronaridine blocks context-induced reinstatement following cocaine self-administration in rats.

Polston, Pritchett, Sell et al.· Pharmacol Biochem Behav· 2012· PMID: 22885280
Preclinical (Animal)

Numerous studies utilizing drug self-administration have shown the importance of conditioned cues in maintaining and reinstating addictive behaviors. However, most used simple cues that fail to replicate the complexity of cues present in human craving and addiction. We have recen...

Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga.

Paškulin, Jamnik, Danevčič et al.· J Ethnopharmacol· 2012· PMID: 22751004
Preclinical (Lab)

The root bark of iboga plant-Tabernanthe iboga has been used traditionally in Central Africa as a psychoactive substance in religious rituals, while in smaller doses it is appreciated due to its stimulant properties. The iboga root bark, iboga extract or pure ibogaine are being r...

Life-threatening complications of ibogaine: three case reports.

Paling, Andrews, Valk et al.· Neth J Med· 2012· PMID: 23123541
Case Report

Ibogaine is a naturally occurring psychoactive alkaloid extracted from the roots of the Tabernanthe iboga plant, which in alternative medicine is used to treat drug dependency. However, this upcoming, online advocated therapy can be dangerous due to its potentially lethal adverse...

Fatalities temporally associated with the ingestion of ibogaine.

Alper, Stajić, Gill· J Forensic Sci· 2012· PMID: 22268458
Unclassified

Ibogaine is a naturally occurring psychoactive plant alkaloid that is used globally in medical and nonmedical settings for opioid detoxification and other substance use indications. All available autopsy, toxicological, and investigative reports were systematically reviewed for t...

The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.

Bulling, Schicker, Zhang et al.· J Biol Chem· 2012· PMID: 22451652
Preclinical (Animal)

Ibogaine, a hallucinogenic alkaloid proposed as a treatment for opiate withdrawal, has been shown to inhibit serotonin transporter (SERT) noncompetitively, in contrast to all other known inhibitors, which are competitive with substrate. Ibogaine binding to SERT increases accessib...

Ibogaine and the inhibition of acetylcholinesterase.

Alper, Reith, Sershen· J Ethnopharmacol· 2012· PMID: 22200647
Preclinical (Animal)

Ibogaine is a psychoactive monoterpine indole alkaloid extracted from the root bark of Tabernanthe iboga Baill. that is used globally in medical and nonmedical settings to treat drug and alcohol addiction, and is of interest as an ethnopharmacological prototype for experimental i...

Ibogaine-associated ventricular tachyarrhythmias.

Pleskovic, Gorjup, Brvar et al.· Clin Toxicol (Phila)· 2012· PMID: 22304378
Case Report

Analysis of electrical brain waves in neurotoxicology: γ-hydroxybutyrate.

Binienda, Beaudoin, Thorn et al.· Curr Neuropharmacol· 2011· PMID: 21886596
Preclinical (Lab)

Advances in computer technology have allowed quantification of the electroencephalogram (EEG) and expansion of quantitative EEG (qEEG) analysis in neurophysiology, as well as clinical neurology, with great success. Among the variety of techniques in this field, frequency (spectra...

Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine.

Taraschenko, Maisonneuve, Glick· Physiol Behav· 2011· PMID: 21324333
Preclinical (Animal)

Evidence suggests that the development of diet-induced obesity in males and females might be mediated by distinct mechanisms, warranting different treatment approaches. In previous studies from this laboratory, a high sucrose diet induced excessive weight gain in female but not i...

Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats.

McCallum, Taraschenko, Hathaway et al.· Psychopharmacology (Berl)· 2011· PMID: 21210086
Preclinical (Animal)

18-methoxycoronaridine (18-MC), a selective antagonist of α3β4 nicotinic receptors, has been previously shown, in rats, to reduce the self-administration of several drugs of abuse, reduce operant responding for sucrose, and prevent the development of sucrose-induced obesity. It h...

Doctor is suspended for prescribing a drug for pornography "addiction" without giving the risks.

Dyer· BMJ· 2011· PMID: 22006945
Unclassified

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.

Glick, Sell, McCallum et al.· Eur J Pharmacol· 2011· PMID: 21871879
Preclinical (Animal)

18-Methoxycoronaridine (18-MC), a putative anti-addictive agent, has been shown to decrease the self-administration of several drugs of abuse in rats. 18-MC is a potent antagonist at α3β4 nicotinic receptors. Consistent with high densities of α3β4 nicotinic receptors being locate...

Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine.

Taraschenko, Maisonneuve, Glick· Physiol Behav· 2011· PMID: 20951714
Preclinical (Animal)

Evidence suggests that the development of obesity in males and females might be mediated by distinct mechanisms, warranting different treatment approaches. In previous studies from this laboratory, a high sucrose diet induced excessive weight gain in female Sprague-Dawley rats an...

The need for ibogaine in drug and alcohol addiction treatment.

Donnelly· J Leg Med· 2011· PMID: 21391058
Preclinical (Animal)

Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.

Arias, Feuerbach, Targowska-Duda et al.· Int J Biochem Cell Biol· 2011· PMID: 21642011
Preclinical (Animal)

The interaction of ibogaine analogs with nicotinic acetylcholine receptors (AChRs) in different conformational states was studied by functional and structural approaches. The results established that ibogaine analogs: (a) inhibit (±)-epibatidine-induced Ca²⁺ influx in human embry...

Ibogaine-associated psychosis in schizophrenia: a case report.

Houenou, Homri, Leboyer et al.· J Clin Psychopharmacol· 2011· PMID: 21881451
Case Report
← PrevPage 7 / 14Next →